HomeLarge Type Edition
HOME ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
PubMed
Right arrow PubMed Citation
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59:B416-B423 (2004)
© 2004 The Gerontological Society of America

Angiotensin-Converting Enzyme Inhibition, Body Composition, and Physical Performance in Aged Rats

Christy S. Carter1,2,, Matteo Cesari1, Walter T. Ambrosius3, Nan Hu3, Debra Diz2,4, Sherry Oden2,4, William E. Sonntag2 and Marco Pahor1

1 Sticht Center on Aging
2 Department of Physiology and Pharmacology
3 Department of Public Health Sciences
4 The Hypertension Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina.

Address correspondence to Christy S. Carter, PhD, Department of Internal Medicine, Section on Geriatrics and Gerontology, Wake Forest University School of Medicine, 1 Medical Center Blvd., Winston-Salem NC 27157. E-mail: chrcarte{at}wfubmc.edu

This study was designed to test the effects of angiotensin-converting enzyme (ACE) inhibition on body composition and physical performance in aged rats. Male Brown Norway x F344 rats were randomized to receive daily injections of enalapril (40 mg/kg or 80 mg/kg) or saline from 24 to 30 months of age. Body composition was determined using dual-energy X-ray absorptiometry (DXA), and physical performance was assessed using the grip strength and inclined plane procedures. Performance measures were assessed at baseline and monthly thereafter. DXA was performed at baseline, 3 months, and 6 months of follow-up. Compared with the enalapril groups, the saline group experienced a greater 6-month decline in the physical performance measures. Lean body mass declined in both groups; however, the enalapril groups also experienced a significant loss of fat mass. These results suggest that ACE inhibition may prevent age-related declines in physical performance, which may be mediated by a reduction in body fat mass.




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
S. O. Kasper, C. S. Carter, C. M. Ferrario, D. Ganten, L. F. Ferder, W. E. Sonntag, P. E. Gallagher, and D. I. Diz
Growth, metabolism, and blood pressure disturbances during aging in transgenic rats with altered brain renin-angiotensin systems
Physiol Genomics, November 17, 2005; 23(3): 311 - 317.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. B. Kritchevsky, B. J. Nicklas, M. Visser, E. M. Simonsick, A. B. Newman, T. B. Harris, E. M. Lange, B. W. Penninx, B. H. Goodpaster, S. Satterfield, et al.
Angiotensin-Converting Enzyme Insertion/Deletion Genotype, Exercise, and Physical Decline
JAMA, August 10, 2005; 294(6): 691 - 698.
[Abstract] [Full Text] [PDF]




HOME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by The Gerontological Society of America.